We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Genital Warts Decline Thanks to HPV Vaccine

By HospiMedica International staff writers
Posted on 29 Apr 2013
A new study reveals that the incidence of genital warts declined by more than 90% in adolescent and teenage girls following the introduction of the human papillomavirus (HPV) vaccine in Australia.

Researchers at the University of New South Wales (Sydney, Australia), the University of Melbourne (Australia), and other institutions conducted a trend analysis study of surveillance data involving 85,770 Australian born patients to measure the effect on genital warts of the national HPV vaccination program in Australia, which started in mid-2007. More...
Data were collated from eight sexual health services from 2004 to 2011, with the two largest clinics also collecting self-reported HPV vaccination status from 2009. The main outcome measure was trends in proportion of new patients diagnosed as having genital warts.

The results showed that large declines occurred in the proportions of women diagnosed as having genital warts in the vaccination period—from 11.5% in 2007 to 0.85% in 2011 in women under 21, and from 11.3% in 2007 to 3.1% in 2011 in women 21–30; no significant decline in wart diagnoses was seen in women over 30 years of age. Significant declines also occurred in proportions of under 21 year old and 21–30 year old heterosexual men diagnosed as having genital warts; again, no significant decline in genital wart diagnoses was seen in heterosexual men over 30 years of age. Significantly, in 2011 no genital wart diagnoses were made among 235 women under 21 years of age who reported prior HPV vaccination. The study was published in April 18, 2013, in BMJ.

“The significant declines in the proportion of young women found to have genital warts and the absence of genital warts in vaccinated women in 2011 suggests that the human papillomavirus vaccine has high efficacy outside the trial setting,” concluded lead author Basil Donovan, MD, of the University of New South Wales, and colleagues. “Large declines in diagnoses of genital warts in heterosexual men are probably due to herd immunity.”

In 2007 Australia became one of the first countries to implement a nationally funded program of HPV vaccination, offering free vaccination to girls aged 12–13 years in schools. In addition, from 2007 to 2009 two catch-up programs were implemented, one for 13–18 year old schoolgirls and the other for 18–26 year old women in the community. The quadrivalent vaccine provides protection against HPV types 6 and 11, which cause genital warts, in addition to the cancer causing types 16 and 18.

Related Links:

University of New South Wales
University of Melbourne



Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Syringe Pump
SP50 Series
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.